Cognitive Behavioral Therapy for Insomnia in the Context of Cardiovascular Conditions

Area of Science:

• Cardiology
• Sleep Medicine
• Behavioral Science

Background:

• Cardiovascular disease (CVD) is a leading global cause of mortality and morbidity.
• Insomnia is highly prevalent in individuals with CVD, impacting their quality of life.
• The effects of insomnia treatments on CVD outcomes are not well understood.

Purpose of the Study:

• To review the literature on Cognitive Behavioral Therapy for Insomnia (CBT-I) effects in patients with CVD.
• To examine CBT-I's impact on sleep, biological markers, symptoms, function, and quality of life.
• To suggest future research and clinical practice implications.

Main Methods:

• Literature review of studies examining CBT-I in the context of CVD.
• Analysis of effects on sleep parameters, cardiovascular biomarkers, and patient-reported outcomes.
• Synthesis of findings to identify research gaps and clinical implications.

Main Results:

• Limited evidence suggests CBT-I improves biomarkers associated with CVD risk.
• CBT-I demonstrates potential in enhancing cardiovascular health by addressing chronic insomnia's negative biological effects.
• Improvements were noted in symptom burden, functional performance, and quality of life.

Conclusions:

• CBT-I holds promise for managing insomnia in CVD patients, potentially reducing cardiovascular morbidity.
• Further research is essential to determine long-term outcomes, the role of biomarkers, and optimal delivery methods for CBT-I in cardiac conditions.